By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Verastem, Inc. 

215 First Street
Suite 440
Cambridge  Massachusetts  02142  U.S.A.
Phone: 617-858-0338 Fax: n/a


Company News
Verastem, Inc. (VSTM) Presents Encouraging Scientific Data On The Preferential Targeting Of Cancer Stem Cells At The 2015 AACR Annual Meeting 4/22/2015 11:04:12 AM
Verastem, Inc. (VSTM) To Present Data At The 2015 American Association for Cancer Research Annual Meeting 3/19/2015 11:30:52 AM
Verastem, Inc. (VSTM) Reports Year-End 2014 Financial Results 3/10/2015 11:17:36 AM
Verastem, Inc. (VSTM) To Present At 27th Annual ROTH Conference 3/3/2015 12:14:15 PM
Verastem, Inc. (VSTM) Receives Orphan Drug Designation From FDA For VS-5584 In Mesothelioma 2/12/2015 12:11:54 PM
Verastem, Inc. (VSTM) Announces The Grant Of Inducement Awards 2/5/2015 9:36:54 AM
Verastem, Inc. (VSTM) To Present At Upcoming Investor Conferences 2/3/2015 12:13:40 PM
Verastem, Inc. (VSTM) Announces Pricing Of Public Offering Of Common Stock 1/23/2015 10:24:09 AM
Verastem, Inc. (VSTM) Announces Proposed Public Offering Of Common Stock 1/21/2015 12:52:38 PM
Verastem, Inc. (VSTM) Doses First Patient In Phase 1 Clinical Trial Evaluating VS-5584 In Combination With VS-6063 In Mesothelioma 1/20/2015 11:04:58 AM